My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.

    Kase CS, O'Neal AM, Fisher M, Girgis GN, Ordia JI.

    Ann Intern Med. 1990 Jan 1;112(1):17-21.PMID: 2104561 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.

    Kase CS, Pessin MS, Zivin JA, del Zoppo GJ, Furlan AJ, Buckley JW, Snipes RG, LittleJohn JK.

    Am J Med. 1992 Apr;92(4):384-90.PMID: 1558085 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.

    Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al.

    Neurology. 1995 Apr;45(4):649-58.PMID: 7723950 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

    Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ.

    Ann Intern Med. 1998 Oct 15;129(8):597-604.PMID: 9786806 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

    Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML.

    Circulation. 1991 Feb;83(2):448-59.PMID: 1899364 [PubMed - indexed for MEDLINE]Related articles

    6.

    TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

    Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E.

    Circulation. 1998 Dec 22-29;98(25):2805-14.PMID: 9860780 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.

    Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, White HD, Gore JM, Simoons ML, Weaver WD, Green CL, Topol EJ, Califf RM.

    Circulation. 1998 Oct 6;98(14):1376-82.PMID: 9760291 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intracerebral hematoma related to thrombolysis for myocardial infarction.

    Kaufman HH, McAllister P, Taylor H, Schmidt S.

    Neurosurgery. 1993 Nov;33(5):898-900; discussion 900-1.PMID: 8264890 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction]

    Valentín Segura V, Valls Grima F, Broch Porcar MJ, Miralles Serrano L, Olivares Toledo D, Alvarez Cebrián F.

    Rev Esp Cardiol. 1994 Dec;47(12):836-8. Spanish. PMID: 7855379 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cerebral venous congestion as indication for thrombolytic treatment.

    Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.

    Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87.PMID: 17573553 [PubMed - indexed for MEDLINE]Related articles

    11.

    Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.

    Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J.

    Stroke. 2004 Sep;35(9):2123-7. Epub 2004 Jul 8.PMID: 15243150 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.

    Da Silva VF, Bormanis J.

    Neurosurgery. 1992 Jun;30(6):943-5. Review.PMID: 1614602 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.

    Giugliano RP, McCabe CH, Antman EM, Cannon CP, Van de Werf F, Wilcox RG, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) Investigators.

    Am Heart J. 2001 May;141(5):742-50.PMID: 11320361 [PubMed - indexed for MEDLINE]Related articles

    14.

    Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

    Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Van de Werf F, Aylward PE, Topol EJ, et al.

    Circulation. 1995 Nov 15;92(10):2811-8.PMID: 7586246 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Unsuspected vasculitis and intracranial hemorrhage following thrombolysis.

    Srinivasan G, Boschman C, Roth SI, Hendel RC.

    Clin Cardiol. 1997 Jan;20(1):84-6.PMID: 8994745 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.

    Carlson SE, Aldrich MS, Greenberg HS, Topol EJ.

    Arch Neurol. 1988 Oct;45(10):1070-3.PMID: 3140769 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction.

    Wijdicks EF, Jack CR Jr.

    Stroke. 1993 Apr;24(4):554-7.PMID: 8465362 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

    Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ.

    Stroke. 1998 Mar;29(3):563-9.PMID: 9506593 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

    Van de Werf F, Arnold AE.

    BMJ. 1988 Nov 26;297(6660):1374-9.PMID: 3146370 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.

    von Kummer R, Hacke W.

    Stroke. 1992 May;23(5):646-52.PMID: 1579960 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity